Technical and clinical comparison of two fully automated methods for the immunoassay of CA 125 in serum

Journal of Immunological Methods

Volumn 225, Issue 1-2, 1999, Pages 1-8

  Yan, Guifeng ^a,b   Ju, Huangxian ^a   Liang, Zhichao ^b   Zhang, Tingqing ^b  

^a NANJING UNIVERSITY   (China)

^b JIANGSU CANCER HOSPITAL   (China)

Author keywords

CA 125; Chemiluminescent enzyme immunoassay; Enzyme linked immunosorbent assay; Immunoradiometric assay; Ovarian carcinoma

Indexed keywords

CA 125 ANTIGEN; TUMOR ANTIGEN;

ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; REPRODUCIBILITY;

CA-125 ANTIGEN; CHEMILUMINESCENT MEASUREMENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNORADIOMETRIC ASSAY; OVARIAN NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0033067405     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(99)00023-X     Document Type: Article

References (19)

1. Bast R.C., Lazarus H., Feeney M., Knapp R.C. Reactivity of a monoclonal antibody with human ovarian carcinoma. Am. Assoc. Cancer Res. 21:1980;207.
2. Bast R.C., Feeney M., Lazarus H., Nadler L.M., Colvin R.B., Knapp R.C. Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin. Invest. 68:1981;1331.
3. Bast R.C., Klug T.L., St. John E.et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. New Engl. J. Med. 309:1983;883.
4. Boerman O.C., Thomas C.M.G., Segers M.F.G., Kenemans P., Lovgren T., Zurawski V.R., Halsma H.J., Poels L.G. Time-resolved immunofluorometric assay for the ovarian carcinoma-associated antigenic determinant CA 125 in serum. Clin. Chem. 33:1987;2191.
5. Bonfrer J.M.G., Baan A.W., Jansen E., Lentfer D., Kenemans P. Technical evaluation of three second generation CA 125 assays. Eur. J. Clin. Chem. Clin. Biochem. 32:1994;201.
6. Deger, A.U.W., 1993. Method for the determination of an immunologically bindable substance. Eur. Pat. Appl. EP 540, 037 (Cl. G01N33/543).
7. Einhorn N., Bast R.C., Knapp R.C., Tjernberg B., Zurawski V.R. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer. Obstet. Gynecol. 67:1986;414.
8. Endo K., Matsuoka Y., Nakashima T., Fujli S., Kunimatsu M.et al. Development of a new sensitive IRMA for CA 125: mixed use of two monoclonal antibodies reaction with separate epitopes. J. Tumor Marker Oncol. 3:1988;65.
9. Hashimoto T., Ohba N., Matsubara F. Discordant CA 125 measurements in normal healthy women (Tech Brief). Clin. Chem. 36:1990;1377.
10. Kakizaki J., Miyazaki T., Maeda T. Basic studies of ball ELISA CA 125-II kit for detection of serum cancer antigen 125. Kaku Igaku. 30:1993;807.
11. Kenemans P., Bon G.G., Kessler A.C., Verstraeten A.A., van Kamp G.J. Multicenter technical and clinical evaluation of a fully automated enzyme immunoassay for CA 125. Clin. Chem. 38:1992;1466.
12. Klug T.L., Bast R.C., Niloff J.M., Knapp R.C., Zurawski V.R. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. Cancer Res. 44:1984;1048.
13. Lavin P., Knapp R.C., Malkasian G., Whitney C.W., Berck J.C., Bast R.C. CA 125 for the monitoring of ovarian carcinoma during primary therapy. Obstet. Gynecol. 69:1987;223.
14. Madersbacher S., Berger P. Double wavelength measurement of 3,3′,5,5′-tetramethylbenzidine (YMB) provides a three-fold enhancement of the ELISA measuring range. J. Immunol. Methods. 138:1991;121.
15. Nishizono I., Iida S., Suzuki N., Kawada H., Murakami H., Ashihara Y., Okada M. Rapid and sensitive chemiluminescent enzyme immunoassay for measuring tumor markers. Clin. Chem. 37:1991;1639.
16. Shima Y., Tsukada T., Nakayarna T. Evaluation of automated chemiluminescent enzyme immunoassay system, Lumipulse 1200: I. Characteristics of the instrument and properties of the reagents. Igaku to Yakugaku. 28:1992;1247.
17. Zucchelli G.C., Pilo A., Jaworek D., Masini S., Chiesa M.R. Immunoassay of CEA, CA19-9, CA 125 and CA 15-3 on the automated systems ES 300 and ES 600: methodological evaluation from a multicenter collaborative study. Eur. J. Clin. Chem. Clin. Biochem. 30:1992;875.
18. Zucchelli G.C., Pilo A., Chiesa M.R., Masini S., Clerico A. Analytical performance of CA19-9, CA 125 and CA15-3 assay as observed through an external quality assessment program. Int. J. Biol. Markers. 9:1994;43.
19. Zurawski V.R., Broderick S.F., Pickens P., Knapp R.C., Bast R.C. Serum CA 125 levels in a group of non-hospitalized women: relevance for the early detection of ovarian cancer. Obstet. Gynecol. 69:1987;606.